Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You speak English.
- You are between 18 and 80 years old.
- For certain parts of this study, you have been diagnosed with a type of slow-growing blood cancer called indolent non-Hodgkin lymphoma (including CLL/SLL), confirmed through a laboratory test of tissue or cells.
Who may not be able to join:
- If you are a healthy volunteer (for one specific part of the study), you may not be eligible if you have a known heart or lung condition — such as heart disease, blocked arteries, COPD, or asthma.
- If you are a healthy volunteer, you may not be eligible if you have a bone, joint, or muscle problem that would prevent you from exercising.
- If you are a healthy volunteer, you may not be eligible if you are a current or former smoker.
- If you have indolent non-Hodgkin lymphoma and are currently receiving treatment, you must have at least 8 weeks of treatment still planned ahead to be eligible.
- If you have finished treatment, you must have completed it at least 6 months ago and must not have any treatments planned during the 12-week study period.
- If you have not yet started treatment, you must not have any treatments scheduled during your time in the study.
- You may not be eligible if you have uncontrolled high blood pressure or a heart condition, or if your cancer doctor has not approved your participation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess circulating immune cell abundance and function pre-intervention; Assess circulating immune cell mobilization and function post-intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.